Works matching IS 17526981 AND DT 2023 AND VI 17 AND IP 12


Results: 17
    1
    2
    3
    4
    5
    6

    Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive‐stage small‐cell lung cancer patients (DURABLE study).

    Published in:
    Clinical Respiratory Journal, 2023, v. 17, n. 12, p. 1361, doi. 10.1111/crj.13715
    By:
    • Zhang, Bo;
    • Zhong, Hua;
    • Shi, Chunlei;
    • Gao, Zhiqiang;
    • Zhong, Runbo;
    • Gu, Aiqin;
    • Wang, Weimin;
    • Chu, Tianqing;
    • Xiong, Liwen;
    • Zhang, Wei;
    • Wang, Huimin;
    • Zhang, Xueyan;
    • Han, Baohui
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Issue Information.

    Published in:
    Clinical Respiratory Journal, 2023, v. 17, n. 12, p. 1201, doi. 10.1111/crj.13509
    Publication type:
    Article